MedPath

Trauma Therapy for Psychosis: Eye Movement Desensitisation and Reprocessing (EMDR) for people with a psychotic illness

Not Applicable
Completed
Conditions
Mental health difficuties
Mental and Behavioural Disorders
Registration Number
ISRCTN43816889
Lead Sponsor
Cornwall Foundation NHS Trust (UK)
Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38056231/ (added 07/12/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
36
Inclusion Criteria

Patients with a psychotic illness without comorbid PTSD currently receiving care from secondary care psychiatric services between the ages of 18-65 years

Exclusion Criteria

Having a severe learning difficulty, being unable to speak English or travel to the appointments. Having a serious concern about risk or being placed in a locked psychiatric unit.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Impact of Events Scale (IES) measured at baseline, then after 10 weeks (to allow for the up to 8 week therapy course to complete) and then after 6 months from baseline.
Secondary Outcome Measures
NameTimeMethod
1. Positive and Negative Symptoms of Schizophrenia Scale (PANSS)<br>2. Subjective Quality of Life (MANSA)<br>3. PTSD Checklist (PCL) <br><br>The measures will be done at baseline, then after 10 weeks (to allow for the up to 8 week therapy course to complete) and then after 6 months from baseline.
© Copyright 2025. All Rights Reserved by MedPath